Sonoma Pharmaceuticals GAAP EPS of -$0.63 beats by $0.06, revenue of $3.6M misses by $0.46M
Source: SeekingAlpha
2025-02-05 17:05:31 ET
More on Sonoma Pharmaceuticals
- Seeking Alpha’s Quant Rating on Sonoma Pharmaceuticals
- Historical earnings data for Sonoma Pharmaceuticals
- Financial information for Sonoma Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Sonoma Pharmaceuticals GAAP EPS of -$0.63 beats by $0.06, revenue of $3.6M misses by $0.46M
Sonoma Pharmaceuticals Inc.
NASDAQ: SNOA
SNOA Trading
-2.34% G/L:
$2.0899 Last:
19,327 Volume:
$2.13 Open:
SNOA Latest News
March 24, 2026 08:30:00 am
Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart
March 18, 2026 08:30:00 am
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin
February 10, 2026 04:10:00 pm
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results
SNOA Stock Data
$5,060,701
1,667,054
3.53%
11
N/A
Pharmaceuticals
Healthcare
US
Boulder
